Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN ETEXILATE vs DACTINOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABIGATRAN ETEXILATE vs DACTINOMYCIN: Safety Overview

Metric DABIGATRAN ETEXILATE DACTINOMYCIN
Total FAERS Reports 37,091 2,858
Deaths Reported 5,806 507
Death Rate 15.7% 17.7%
Hospitalizations 21,235 721
Average Patient Age 74.4 yrs 18.8 yrs
% Female Patients 45.8% 65.9%
FDA Approval Date Aug 12, 2024 Approved Prior to Jan 1, 1982
Manufacturer Apotex Corp. Eugia US LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued